Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 114 results:
Συντάκτης Τίτλος [ Τύπος] Έτος Φίλτρα: Συντάκτης is Doumas, Michael [Clear All Filters]
Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis..
Curr Vasc Pharmacol. 16(2), 104-106.
(2018).
(2017). Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension..
Curr Vasc Pharmacol. 16(4), 393-400.
(2018). The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins..
Curr Pharm Des. 23(10), 1477-1483.
(2017). Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis..
J Hypertens. 35(9), 1750-1757.
(2017). The effect of SGLT2 inhibitors on cardiovascular events and renal function..
Expert Rev Clin Pharmacol. 10(11), 1251-1261.
(2017). Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review..
Curr Med Res Opin. 29(10), 1263-74.
(2013). Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study..
Am J Nephrol. 45(2), 136-145.
(2017). Effects of hypertension and antihypertensive therapy on sexual function in the elderly: the jury is still out..
J Hypertens. 31(9), 1917-8.
(2013). Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes..
N Engl J Med. 378(10), 967.
(2018). Erectile dysfunction in chronic kidney disease: From pathophysiology to management..
World J Nephrol. 4(3), 379-87.
(2015). Exercise capacity and all-cause mortality in prehypertensive men..
Am J Hypertens. 22(7), 735-41.
(2009). Exercise capacity and mortality in hypertensive men with and without additional risk factors..
Hypertension. 53(3), 494-9.
(2009). Exercise capacity and mortality in older men: a 20-year follow-up study..
Circulation. 122(8), 790-7.
(2010). Gender differences in hypertension: myths and reality..
Curr Hypertens Rep. 15(4), 321-30.
(2013). Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: A systematic review and meta-analysis of RCTs..
Diabetes Res Clin Pract. 158, 107927.
(2019). A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure..
Blood Press. 18(5), 261-7.
(2009). Hypertension and sexual dysfunction: time to act..
J Hypertens. 29(2), 403-7.
(2011). Hyperuricemia as a risk factor for cardiovascular disease..
Expert Rev Cardiovasc Ther. 13(1), 19-20.
(2015). Impact of Cardiorespiratory Fitness on Mortality in Black Male Veterans With Resistant Systemic Hypertension..
Am J Cardiol. 120(9), 1568-1571.
(2017). Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed..
J Am Soc Hypertens. 10(8), 613-7.
(2016). Insomnia and hypertension: A misty landscape..
J Clin Hypertens (Greenwich). 21(6), 835-837.
(2019). Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study..
Lancet. 381(9864), 394-9.
(2013). Interventional management of resistant hypertension..
Lancet. 373(9671), 1228-30.
(2009). Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk..
J Hypertens. 28(11), 2299-308.
(2010).